We are live on ! Find out more
SWTX

SpringWorks Therapeutics
SWTX

Delisted

SWTX was delisted on the 30th of June, 2025.

Back to rankings

222 hedge funds and large institutions have $3.53B invested in SpringWorks Therapeutics in 2025 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 83 increasing their positions, 69 reducing their positions, and 132 closing their positions.

New
Increased
Maintained
Reduced
Closed

839% more call options, than puts

Call options by funds: $465M | Put options by funds: $49.6M

100% more funds holding in top 10

Funds holding in top 10: 9 → 18 (+9)

20% more repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 69

7% more capital invested

Capital invested by funds: $3.29B → $3.53B (+$235M)

0.13% more ownership

Funds ownership: 99.46% → 99.59% (+0.13%)

27% less funds holding

Funds holding: 306 → 222 (-84)

61% less first-time investments, than exits

New positions opened: 51 | Existing positions closed: 132

Holders
222
Holders Change
-84
Holders Change %
-27.45%
% of All Funds
2.92%
Holding in Top 10
18
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+100%
% of All Funds
0.24%
New
51
Increased
83
Reduced
69
Closed
132
Calls
$465M
Puts
$49.6M
Net Calls
+$416M
Net Calls Change
+$248M

Top Buyers

Rank Fund Capital Flow
1
GCL
Glazer Capital LLC
New York
+$183M
2
Fidelity International
Fidelity International
Bermuda
+$134M
3
TAL
TIG Advisors LLC
New York
+$105M
4
BCM
Beryl Capital Management
California
+$94.2M
5
MF
Magnetar Financial
Illinois
+$91.3M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$498M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$112M
3
PCH
Polar Capital Holdings
United Kingdom
-$77.2M
4
WP
Woodline Partners
California
-$76M
5
Pictet Asset Management
Pictet Asset Management
Switzerland
-$73.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
276
Algert Global
California
– -$1.95M -44,180 Closed
TCA
277
Troluce Capital Advisors
Puerto Rico
– -$1.85M -41,918 Closed
Point72 Asset Management
278
Point72 Asset Management
Connecticut
– -$1.75M -39,645 Closed
BCI
279
Brinker Capital Investments
Pennsylvania
– -$1.6M -36,222 Closed
BCM
280
Bayesian Capital Management
New York
– -$1.58M -35,814 Closed
XT
281
XTX Topco
Cayman Islands
– -$1.55M -35,027 Closed
SC
282
Slotnik Capital
Texas
– -$1.54M -35,000 Closed
CF
283
Corebridge Financial
Texas
– -$1.49M -33,678 Closed
RC
284
Rangeley Capital
Connecticut
– -$1.47M -33,400 Closed
BC
285
BIT Capital
Germany
– -$1.34M -30,257 Closed
PHS
286
PFM Health Sciences
California
– -$1.17M -26,437 Closed
SAM
287
Sectoral Asset Management
Quebec, Canada
– -$1.12M -25,325 Closed
KCM
288
Kennedy Capital Management
Missouri
– -$1.11M -25,222 Closed
Stifel Financial
289
Stifel Financial
Missouri
– -$1.11M -25,102 Closed
MS
290
Maven Securities
Jersey
– -$1.1M -25,010 Closed
Nomura Holdings
291
Nomura Holdings
Japan
– -$1.04M -23,500 Closed
FLC
292
Fifth Lane Capital
Texas
– -$997K -22,584 Closed
SO
293
STRS Ohio
Ohio
– -$958K -21,700 Closed
Ensign Peak Advisors
294
Ensign Peak Advisors
Utah
– -$849K -19,241 Closed
Wolverine Trading
295
Wolverine Trading
Illinois
– -$852K -19,143 Closed
HT
296
Headlands Technologies
Illinois
– -$807K -18,285 Closed
ECM
297
ExodusPoint Capital Management
New York
– -$791K -17,785 Closed
ASRS
298
Arizona State Retirement System
Arizona
– -$752K -17,049 Closed
JGC
299
J. Goldman & Co
New York
– -$704K -15,951 Closed
CWM
300
CIBC World Markets
New York
– -$673K -15,254 Closed
10 11
12
13 14

SWTX Hedge Fund Activity: Q2 2025 in Review

222 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q2 2025, worth a combined $3.53B — up 7.1% from $3.29B a quarter earlier.

Sellers outnumbered buyers: 132 funds closed out of SWTX and 51 opened new positions — a net loss of 81 holders — while 69 trimmed existing stakes and 83 added.

The largest buyer was Glazer Capital LLC, opening a new position worth an estimated $183M. The largest seller was Fidelity Investments, cutting an estimated $498M.

  • 222 institutional investors held SpringWorks Therapeutics (SWTX) as of Q2 2025, down from 306 in Q1 2025.
  • Funds reported $3.53B of SpringWorks Therapeutics stock for Q2 2025, up 7.1% quarter-over-quarter.
  • 51 funds opened new SpringWorks Therapeutics positions in Q2 2025 and 132 closed out, a net change of -81 holders.
  • The largest SpringWorks Therapeutics buyer in Q2 2025 was Glazer Capital LLC, an estimated $183M added.
  • The largest SpringWorks Therapeutics seller in Q2 2025 was Fidelity Investments, an estimated $498M sold.

Based on aggregated 13F filings for Q2 2025.